{"id":"W2060696690","doi":"10.1016/j.lungcan.2013.11.020","title":"Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Merck Sharp and Dohme","keywords":"Medicine; Erlotinib; Internal medicine; Neutropenia; Oncology; Lung cancer; Adverse effect; Surgery; Cancer; Epidermal growth factor receptor; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001447556,0.001948596,0.003435514,0.0004517126,0.0004626356,0.001376361,0.001031259,0.001546269,0.008561474],"category_scores_gemma":[0.001711188,0.001054103,0.001677013,0.0004366515,0.001378002,0.001630137,0.000494974,0.003858104,0.001366813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001538908,"about_ca_system_score_gemma":0.001555117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001781268,"about_ca_topic_score_gemma":0.005387852,"domain_scores_codex":[0.9994641,0.0002714458,0.00002352886,0.00009973948,0.00003086442,0.0001104271],"domain_scores_gemma":[0.9992111,0.0002148836,0.0001470368,0.0000717123,0.00004874002,0.0003066524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9812348,0.004568965,0.0003711271,0.000270588,0.0004932536,0.000024931,0.00003239276,0.0004947301,0.00173164,0.0001383945,0.0007470534,0.009892122],"study_design_scores_gemma":[0.9610425,0.03643491,0.0008297262,0.00001398337,0.0002407279,0.00002537321,0.00002025991,0.0004070912,0.0002211358,0.0001687644,0.0005837553,0.00001178589],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851163,0.003458725,0.0008155112,0.001179394,0.001014567,0.00312818,0.001549182,0.0001694264,0.003568846],"genre_scores_gemma":[0.9844563,0.002086947,0.001595245,0.00151547,0.0005048842,0.003305251,0.001597249,0.00005178495,0.004886934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008561474,"threshold_uncertainty_score":0.02864093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009580312840794003,"score_gpt":0.2976431150917498,"score_spread":0.2880628022509558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}